Latest Breaking News On - Alexis feinberg - Page 1 : comparemela.com

Sparrow Pharmaceuticals to Present on HSD-1 Inhibitor Clofutriben (SPI-62) for Polymyalgia Rheumatica at the European Congress of Rheumatology 2024

PORTLAND, Ore. (BUSINESS WIRE) Jun 6, 2024

Alexis feinbergDavid katzSparrow pharmaceuticalsEuropean congressChief scientific officerHydroxysteroid dehydrogenase typeModulates prednisolone immuneMusculoskeletal efficacyResorption biomarkersPolymyalgia rheumaticaBusiness wire

Gameto Announces New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solution for Fertility Care

Gameto Announces New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solution for Fertility Care
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAlexis feinbergChristian krammeDina radenkovicMartin varsavskyVitro maturation solutionChief executive officerChief scientific officerNorth americaPrelude fertility

Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024

Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South africaComunidad autonoma de catalunaUnited statesJeffrey fischerStephanie carringtonAlexis feinbergJeff fischerGeraldw fischerEuropean congressUniversity of pretoriaOne healthClinical microbiologyInfectious diseasesPresident longhorn vaccinesLonghorn vaccines

Longhorn Vaccines and Diagnostics LLC: Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024

Longhorn Vaccines and Diagnostics LLC: Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South africaComunidad autonoma de catalunaUnited statesJeff fischerStephanie carringtonAlexis feinbergDennis riedlGeraldw fischerJeffrey fischerUniversity of pretoriaEuropean congressOne healthClinical microbiologyInfectious diseasesPresident longhorn vaccinesLonghorn vaccines

Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor

WALTHAM, Mass. & MONTREAL (BUSINESS WIRE) Jan 3, 2024

United statesAlexis feinbergMike crackowerMarcelo bigalVentus presidentVentus chief scientific officer mike crackowerVentus therapeuticsLooking statementsBusiness wire